TEANECK, N.J., April 2, 2019 /PRNewswire/ -- Cognizant (Nasdaq: CTSH) has introduced Cognizant Protocol Creator, a SaaS collaboration product that automates the development of clinical trial protocol documentation. A first for the life sciences industry, Protocol Creator enables clinical...
from PR Newswire: https://ift.tt/2uGhlUD
No comments:
Post a Comment